Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1501 Articles

Lee Jackson | Sep 30, 2020 at 7:42 AM EDT

4 Companies in Late-Stage Coronavirus Vaccine Testing: Will Big Pharma Win the Race?

These companies have a very good shot at crossing the finish line first with a COVID-19 vaccine. Even those that…

Jon C. Ogg | Sep 29, 2020 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, CSX, Dominion, JPMorgan, NXP, ONEOK, Pfizer, Square, UPS, WPX Energy and More

Tuesday's top analyst upgrades and downgrades included AbbVie, CSX, Dominion Energy, JPMorgan, NXP Semiconductors, ONEOK, Pfizer, Square, United Parcel Service…

Jon C. Ogg | Sep 23, 2020 at 10:48 AM EDT

The Advantage Johnson & Johnson’s Phase 3 COVID-19 Study Has Over Rivals

The race for the COVID-19 vaccine is still very much on, and Johnson & Johnson just announced the launch of…

Chris Lange | Sep 19, 2020 at 9:26 AM EDT

This Week in Coronavirus News

As an approved COVID-19 vaccine nears completion in terms of clinical trials, what can we expect? In the past couple…

Jon C. Ogg | Sep 2, 2020 at 7:27 PM EDT

As CDC Issues Notice, Stock Market Bets Which Company Gets First COVID-19 Vaccine FDA Approval

America and the rest of the world is getting ready for a vaccine that will help protect public health against…

Jon C. Ogg | Sep 1, 2020 at 8:46 AM EDT

3 COVID-19 Vaccine Trials Are Now in Phase 3, With More on the Way

Three U.S. COVID-19 vaccine trials are now in Phase 3 studies. All three appear to have some serious benefits, but…

Lee Jackson | Aug 27, 2020 at 8:50 AM EDT

Why Dividend-Paying Big Drug Companies May Be the Best Stocks to Own Now

These five dividend-paying large-cap pharmaceutical stocks look like outstanding ideas for nervous investors looking for income and a degree of…

Trey Thoelcke | Aug 26, 2020 at 6:40 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Pfizer, Exxon and Intel above all other Dow Jones industrial…

Jon C. Ogg | Aug 24, 2020 at 6:25 PM EDT

New DJIA Index Changes Going From America 1.0 to America 3.0 With Biotech and Tech

The Dow Jones industrial average changes look a bit strange, and the real effort behind those changes may simply be…

Chris Lange | Aug 21, 2020 at 9:35 AM EDT

The Data Just Keeps Getting Better for Pfizer and BioNTech’s COVID-19 Vaccine

Pfizer and BioNTech provided an update for their coronavirus vaccine that is currently in the late stages of development and…

Trey Thoelcke | Aug 12, 2020 at 6:45 AM EDT

The 5 Most Shorted Dow Stocks

After the caution seen in the prior period, short sellers seemed to find some focus. As of the most recently…

Chris Lange | Aug 5, 2020 at 10:07 AM EDT

5 Large Biotech and Pharma Stocks Are Dirt Cheap, and Not Because of COVID-19

24/7 has compiled a few biopharmaceutical names that have lagged the markets and recently have reported earnings. In a sense,…

Jon C. Ogg | Jul 29, 2020 at 9:11 AM EDT

Top Analyst Upgrades and Downgrades: AMD, Amgen, DexCom, eBay, FireEye, Kraft Heinz, 3M, Pfizer, Seagate, Sonos, Starbucks, T-Mobile and More

Wednesday's top analyst upgrades and downgrades included Advanced Micro Devices, Amgen, DexCom, eBay, FireEye, Kraft Heinz, 3M, Pfizer, Seagate Technology,…

Chris Lange | Jul 28, 2020 at 10:20 AM EDT

COVID-19 Hopes Weren’t the Only Thing Driving Pfizer in Q2

Pfizer released a better than expected second-quarter earnings report and increased its guidance before the markets opened on Tuesday.

Chris Lange | Jul 28, 2020 at 8:46 AM EDT

Pfizer and BioNTech Close in COVID-19 Vaccine With This Next Big Step

Pfizer and BioNTech made another big step in their fight against COVID-19 by initiating their late-stage study for their lead…

1 … 21 22 23 24 25 … 101

Pfizer : PFE

All Pfizer Articles

4 Companies in Late-Stage Coronavirus Vaccine Testing: Will Big Pharma Win the Race?

Top Analyst Upgrades and Downgrades: AbbVie, CSX, Dominion, JPMorgan, NXP, ONEOK, Pfizer, Square, UPS, WPX Energy and More

The Advantage Johnson & Johnson’s Phase 3 COVID-19 Study Has Over Rivals

This Week in Coronavirus News

As CDC Issues Notice, Stock Market Bets Which Company Gets First COVID-19 Vaccine FDA Approval

3 COVID-19 Vaccine Trials Are Now in Phase 3, With More on the Way

Why Dividend-Paying Big Drug Companies May Be the Best Stocks to Own Now

The 5 Most Shorted Dow Stocks

New DJIA Index Changes Going From America 1.0 to America 3.0 With Biotech and Tech

The Data Just Keeps Getting Better for Pfizer and BioNTech’s COVID-19 Vaccine

The 5 Most Shorted Dow Stocks

5 Large Biotech and Pharma Stocks Are Dirt Cheap, and Not Because of COVID-19

Top Analyst Upgrades and Downgrades: AMD, Amgen, DexCom, eBay, FireEye, Kraft Heinz, 3M, Pfizer, Seagate, Sonos, Starbucks, T-Mobile and More

COVID-19 Hopes Weren’t the Only Thing Driving Pfizer in Q2

Pfizer and BioNTech Close in COVID-19 Vaccine With This Next Big Step

More Than 6 Million Children Have Enrolled in Trump Accounts. Here’s Why They Could Become “Tax-Free Millionaires”

Ex-Nasdaq CEO Warns SpaceX’s ‘Unprecedented’ Lockup Expiration Could Flood the Market With $800 Billion in Shares

Top Wall Street Strategist: The S&P 500 Could Hit As High As 8,800 This Year, But a 10-20% Drop May Come First

More Than 6 Million Children Have Enrolled in Trump Accounts. Here's Why They Could Become "Tax-Free Millionaires"

Are Online Banks Safe? What Happens to Your Money if One Fails

More Than 6 Million Children Have Enrolled in Trump Accounts. Here’s Why They Could Become “Tax-Free Millionaires”

Ex-Nasdaq CEO Warns SpaceX’s ‘Unprecedented’ Lockup Expiration Could Flood the Market With $800 Billion in Shares

Pfizer : PFE

All Pfizer Articles

4 Companies in Late-Stage Coronavirus Vaccine Testing: Will Big Pharma Win the Race?

Top Analyst Upgrades and Downgrades: AbbVie, CSX, Dominion, JPMorgan, NXP, ONEOK, Pfizer, Square, UPS, WPX Energy and More

The Advantage Johnson & Johnson’s Phase 3 COVID-19 Study Has Over Rivals

This Week in Coronavirus News

As CDC Issues Notice, Stock Market Bets Which Company Gets First COVID-19 Vaccine FDA Approval

3 COVID-19 Vaccine Trials Are Now in Phase 3, With More on the Way

Why Dividend-Paying Big Drug Companies May Be the Best Stocks to Own Now

The 5 Most Shorted Dow Stocks

New DJIA Index Changes Going From America 1.0 to America 3.0 With Biotech and Tech

The Data Just Keeps Getting Better for Pfizer and BioNTech’s COVID-19 Vaccine

The 5 Most Shorted Dow Stocks

5 Large Biotech and Pharma Stocks Are Dirt Cheap, and Not Because of COVID-19

Top Analyst Upgrades and Downgrades: AMD, Amgen, DexCom, eBay, FireEye, Kraft Heinz, 3M, Pfizer, Seagate, Sonos, Starbucks, T-Mobile and More

COVID-19 Hopes Weren’t the Only Thing Driving Pfizer in Q2

Pfizer and BioNTech Close in COVID-19 Vaccine With This Next Big Step

More Than 6 Million Children Have Enrolled in Trump Accounts. Here’s Why They Could Become “Tax-Free Millionaires”

Ex-Nasdaq CEO Warns SpaceX’s ‘Unprecedented’ Lockup Expiration Could Flood the Market With $800 Billion in Shares

Top Wall Street Strategist: The S&P 500 Could Hit As High As 8,800 This Year, But a 10-20% Drop May Come First

Featured Reads

More Than 6 Million Children Have Enrolled in Trump Accounts. Here's Why They Could Become "Tax-Free Millionaires"

Are Online Banks Safe? What Happens to Your Money if One Fails